Borle Kennedy, Lynd Larry D, Austin Jehannine
Interdisciplinary Studies Program, Faculty of Graduate and Postdoctoral Studies, University of British Columbia, Vancouver, BC, Canada.
Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Centre for Advancing Health Outcomes, Providence Health Research Institute, Vancouver, BC, Canada.
Eur J Hum Genet. 2025 May;33(5):649-657. doi: 10.1038/s41431-025-01838-5. Epub 2025 Mar 27.
In practice, healthcare systems and insurers determine that there is "need" for genetic testing when there is potential for clinical utility. However, it is not currently known how the public understands the need for genetic testing and if this aligns with clinical utility. We recruited participants in Canada through a survey distributed through a market research company (Leger Opinion Panel). Participants who self-reported the need for genetic testing were then purposively sampled to complete a semi-structured virtual interview. We used an interpretive description approach and reflexive thematic analysis. We completed 19 interviews and found that participants' self-identified need for genetic testing was informed by their experiences with genetic information and the perceptions that genetic information is actionable (clinical utility) and has personal meaning (personal utility). Most participants would not be eligible for funded testing based on their personal and family history, however, they had unmet informational and psychological needs, indicating unmet need for genetic counseling. The public understanding of the need for genetic testing is complex and varied. Participants identified many benefits resulting from genetic testing which are not reflected in how need is operationalized in reimbursement decisions, however unmet expectations for testing contributed to medical distrust and dissatisfaction.
在实际操作中,当基因检测具有临床应用潜力时,医疗系统和保险公司会认定存在基因检测“需求”。然而,目前尚不清楚公众如何理解基因检测的需求,以及这是否与临床应用相契合。我们通过一家市场研究公司(莱杰民意调查小组)分发的调查问卷在加拿大招募了参与者。然后,对那些自我报告有基因检测需求的参与者进行有目的的抽样,以完成一次半结构化的虚拟访谈。我们采用了解释性描述方法和反思性主题分析。我们完成了19次访谈,发现参与者自我认定的基因检测需求是由他们对基因信息的体验以及基因信息具有可操作性(临床应用)和个人意义(个人应用)的认知所决定的。大多数参与者基于其个人和家族病史不符合资助检测的条件,然而,他们有未得到满足的信息需求和心理需求,这表明他们对遗传咨询有未得到满足的需求。公众对基因检测需求的理解是复杂多样的。参与者指出基因检测带来了许多益处,但这些益处在报销决策中对需求的操作化方式中并未得到体现,然而,对检测未得到满足的期望导致了医疗不信任和不满。